Get the Stockscreener App
3.98
2.31%
0.09
After Hours:
4.09
0.11
+2.76%
Shattuck Labs Inc stock is traded at $3.98, with a volume of 575.84K.
It is up +2.31% in the last 24 hours and up +28.39% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$3.89
Open:
$3.96
24h Volume:
575.84K
Relative Volume:
1.73
Market Cap:
$251.85M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-2.0622
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
+10.56%
1M Performance:
+28.39%
6M Performance:
+377.56%
1Y Performance:
+213.39%
1-Day Range:
$3.88
$4.09
1-Week Range:
$3.50
$4.09
52-Week Range:
$0.6922
$4.09
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
3.98 | 246.16M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-08-25 | Initiated | Wedbush | Outperform |
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Shattuck Labs (STTK): Citigroup Maintains Neutral Rating, Raises Price Target | STTK Stock News - GuruFocus
Why Shattuck Labs Stock Soared in December - Yahoo Finance
Several Insiders Invested In Shattuck Labs Flagging Positive News - Yahoo Finance
Shattuck Labs (STTK) Price Target Increased by 15.61% to 2.72 - MSN
Shattuck Labs, Inc.'s (NASDAQ:STTK) biggest owners are retail investors who got richer after stock soared 10% last week - simplywall.st
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - AOL.com
Does Shattuck Labs Inc. stock trade at a discount to peersQuarterly Portfolio Review & AI Forecasted Stock Moves - Улправда
Why Shattuck Labs Inc. stock is a must watch in 2025Portfolio Update Report & Daily Volume Surge Trade Alerts - Улправда
Can Shattuck Labs Inc. stock attract ESG capital inflowsEntry Point & Low Risk High Reward Trade Ideas - DonanımHaber
Will Shattuck Labs Inc. stock gain from lower inflationWeekly Stock Summary & Real-Time Market Sentiment Reports - DonanımHaber
How interest rate cuts could boost Shattuck Labs Inc. stockJuly 2025 Price Swings & Daily Price Action Insights - Улправда
How Shattuck Labs Inc. stock performs in rate cut cyclesMarket Activity Recap & Daily Profit Maximizing Trade Tips - Улправда
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Shattuck Labs, Inc. (NASDAQ:STTK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Shattuck Labs (NASDAQ:STTK) Shares Down 1.3%Time to Sell? - MarketBeat
Shattuck Labs (NASDAQ:STTK) Shares Down 1.3% – Time to Sell? - Defense World
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635 - Investing News Network
Shattuck Labs announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Shattuck Labs (NASDAQ: STTK) grants 206K inducement options under Rule 5635(c)(4) - Stock Titan
A History of Outperforming Analyst Forecasts and Beating the Odds: Shattuck Labs Inc (STTK) - setenews.com
Shattuck Labs (STTK) price target increased by 33.33% to 4.08 - MSN
Shattuck Labs (STTK) Price Target Increased by 33.33% to 4.08 - Nasdaq
Why Shattuck Labs Inc. stock remains undervalued2025 Dividend Review & Weekly Top Performers Watchlists - Newser
STTK: Receptor-targeted TL1A therapy shows promise for safer, more effective treatment and rapid development - TradingView
Shattuck Labs, Inc. (STTK) Slides 8% in Pre-market: Without a Clear Catalyst - Stocks Telegraph
It is Poised to be a Bull Market for Shattuck Labs Inc (STTK) - setenews.com
Why hedge funds are buying Shattuck Labs Inc. stockM&A Rumor & Stock Portfolio Risk Control - Newser
HC Wainwright & Co. Upgrades Shattuck Labs (STTK) - Nasdaq
Shattuck's Bowel Disease Treatment Looks Promising: AnalystShattuck Labs (NASDAQ:STTK) - Benzinga
Shattuck Labs Shares Rise After HC Wainwright Upgrade - marketscreener.com
STTK: Shattuck Labs Receives 'Buy' Upgrade from HC Wainwright & Co. | STTK Stock News - GuruFocus
Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright - Investing.com Canada
HC Wainwright Upgrades Shattuck Labs to Buy From Neutral, Price Target is $6 - marketscreener.com
Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Result - Yahoo Finance
Holdings of Shattuck Labs Inc (STTK) are aligned with the stars - Setenews
Hedge funds own 27% of Shattuck Labs, Inc. (NASDAQ:STTK) shares but individual investors control 32% of the company - Yahoo Finance
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Long term hold vs stop loss in Shattuck Labs Inc.2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Why Shattuck Labs Inc. stock could see breakout soonOil Prices & Community Supported Trade Ideas - newser.com
Should I hold or sell Shattuck Labs Inc. stock in 2025Trade Analysis Report & Expert-Curated Trade Recommendations - newser.com
Shattuck Labs to Participate in Upcoming December Investor Conferences - Investing News Network
Shattuck Labs (NASDAQ: STTK) to Join Piper Sandler and Evercore December Events - Stock Titan
Shattuck Labs Reports Improved Financial Performance - MSN
Will Shattuck Labs Inc. stock recover faster than marketWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
CapEx per share of Shattuck Labs, Inc. – NASDAQ:STTK - TradingView
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shattuck Labs Inc Stock (STTK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ashiya Mona | Director |
Aug 25 '25 |
Buy |
0.87 |
6,306,127 |
5,471,826 |
5,255,106 |
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):